Funding for this research was provided by:
United States Agency for International Development (7200AA21CA00011)
NIH/NIAID (UM1 AI106701, UM1 AI068619)
National Institute of Mental Health (K23 MH114760)
Article History
Accepted: 23 June 2022
First Online: 16 September 2022
Declarations
:
: U.M.P. reports consulting agreements from Merck, outside the submitted work. C.A.K has received grant support to the University of California, San Francisco from the Gilead Research Scholars Program in HIV. J.W.M. reports consulting agreements from Gilead Sciences, Inc., and Infectious Disease Connect, and shares/share options from Infectious Disease Connect and Abound Bio, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.